MEDIROM Healthcare Technologies
MRM
3 hedge funds and large institutions have $87.2K invested in MEDIROM Healthcare Technologies in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and closing their positions.
40,264% more capital invested
Capital invested by funds: $216 → $87.2K (+$87K)
50% more funds holding
Funds holding: 2 → 3 (+1)
0.59% more ownership
Funds ownership: 0% → 0.59% (+0.59%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$67.3K |
| 2 |
VF
Virtu Financial
New York
|
+$40.9K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $54.1K | +$67.3K | +18,007 | +60,023% |
|
|
VF
2
Virtu Financial
New York
| $33K | +$40.9K | +10,942 | New |
|
3
Bank of America
Charlotte,
North Carolina
| $75 | – | – | – |
|
MRM Hedge Fund Activity: Q3 2024 in Review
3 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in MEDIROM Healthcare Technologies (MRM) for Q3 2024, worth a combined $87.2K — up 40,264% from $216 a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new MRM positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, adding an estimated $67.3K.
- 3 institutional investors held MEDIROM Healthcare Technologies (MRM) as of Q3 2024, up from 2 in Q2 2024.
- Funds reported $87.2K of MEDIROM Healthcare Technologies stock for Q3 2024, up 40,264% quarter-over-quarter.
- 1 fund opened new MEDIROM Healthcare Technologies positions in Q3 2024 and 0 closed out, a net change of +1 holder.
- The largest MEDIROM Healthcare Technologies buyer in Q3 2024 was UBS Group, an estimated $67.3K added.
Based on aggregated 13F filings for Q3 2024.